Other Cancers Dostarlimab’s Efficacy in Endometrial Cancer by Molecular Subtype: GARNET Study Analysis Jun 01, 2023
Other Cancers Amplifying Anti-Tumor Response: Dose Escalation of Teclistamab in Multiple Myeloma Patients May 30, 2023
Other Cancers Tislelizumab Improves Quality of Life in Asian Patients With Advanced ESCC May 30, 2023
Other Cancers Tislelizumab Plus Chemo Improves Outcomes in Non-Asian Patients With Advanced ESCC May 30, 2023
Other Cancers Sintilimab Plus Chemo Improves Outcomes in Advanced/Metastatic Oesophageal Squamous Cell Carcinoma May 29, 2023